Männel D N, Falk W
Institute of Immunology and Genetics, German Cancer Research Center, Heidelberg, Federal Republic of Germany.
Infect Immun. 1989 Jul;57(7):1953-8. doi: 10.1128/iai.57.7.1953-1958.1989.
Optimal activation of human monocytes in vitro for the biosynthesis of tumor necrosis factor was achieved only with complete S-form lipopolysaccharide. Endotoxin preparations with shorter carbohydrate chains or the lipid A component of lipopolysaccharide were not able to induce release of comparable amounts of tumor necrosis factor by monocytes under the conditions described. The same differences in the level of tumor necrosis factor mRNA were observed. Moreover, addition of these agents to appropriate monocyte-activating substances inhibited the production of tumor necrosis factor. The regulatory implications of this phenomenon are discussed.
仅使用完整的S型脂多糖才能在体外实现人单核细胞的最佳激活,以用于肿瘤坏死因子的生物合成。碳水化合物链较短的内毒素制剂或脂多糖的脂质A成分在所述条件下不能诱导单核细胞释放相当数量的肿瘤坏死因子。在肿瘤坏死因子mRNA水平上也观察到了同样的差异。此外,将这些制剂添加到适当的单核细胞激活物质中会抑制肿瘤坏死因子的产生。本文讨论了这一现象的调节意义。